GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (OTCPK:AWKNF) » Definitions » Equity-to-Asset

Awakn Life Sciences (Awakn Life Sciences) Equity-to-Asset : -0.87 (As of Oct. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Awakn Life Sciences's Total Stockholders Equity for the quarter that ended in Oct. 2023 was $-0.69 Mil. Awakn Life Sciences's Total Assets for the quarter that ended in Oct. 2023 was $0.80 Mil. Therefore, Awakn Life Sciences's Equity to Asset Ratio for the quarter that ended in Oct. 2023 was -0.87.

The historical rank and industry rank for Awakn Life Sciences's Equity-to-Asset or its related term are showing as below:

AWKNF' s Equity-to-Asset Range Over the Past 10 Years
Min: -1.25   Med: 0.35   Max: 0.91
Current: -0.87

During the past 3 years, the highest Equity to Asset Ratio of Awakn Life Sciences was 0.91. The lowest was -1.25. And the median was 0.35.

AWKNF's Equity-to-Asset is ranked worse than
91.69% of 1565 companies
in the Biotechnology industry
Industry Median: 0.67 vs AWKNF: -0.87

Awakn Life Sciences Equity-to-Asset Historical Data

The historical data trend for Awakn Life Sciences's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences Equity-to-Asset Chart

Awakn Life Sciences Annual Data
Trend Jan21 Jan22 Jan23
Equity-to-Asset
0.40 0.50 0.19

Awakn Life Sciences Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.32 0.19 -0.17 -1.26 -0.87

Competitive Comparison of Awakn Life Sciences's Equity-to-Asset

For the Biotechnology subindustry, Awakn Life Sciences's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Awakn Life Sciences's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Awakn Life Sciences's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Awakn Life Sciences's Equity-to-Asset falls into.



Awakn Life Sciences Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Awakn Life Sciences's Equity to Asset Ratio for the fiscal year that ended in Jan. 2023 is calculated as

Equity to Asset (A: Jan. 2023 )=Total Stockholders Equity/Total Assets
=0.632/3.274
=0.19

Awakn Life Sciences's Equity to Asset Ratio for the quarter that ended in Oct. 2023 is calculated as

Equity to Asset (Q: Oct. 2023 )=Total Stockholders Equity/Total Assets
=-0.691/0.796
=-0.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Awakn Life Sciences  (OTCPK:AWKNF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Awakn Life Sciences Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Awakn Life Sciences (Awakn Life Sciences) Business Description

Traded in Other Exchanges
Address
301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2
Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting the people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences (Awakn Life Sciences) Headlines